Highlights and Quick Summary
- EPS Growth (basic) for the quarter ending September 30, 2023 was -48.65%
- Annual EPS Growth (basic) for 2022 was 23.96% (a -100.64% decrease from previous year)
- Annual EPS Growth (basic) for 2021 was -3740.0% (a 5509.72% increase from previous year)
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (basic) of Prime Medicine, Inc.
Most recent EPS Growth (basic)of PRME including historical data for past 10 years.Interactive Chart of EPS Growth (basic) of Prime Medicine, Inc.
Prime Medicine, Inc. EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -48.65% | – | – | – | – |
| 2022 | – | – | – | – | 23.96% |
| 2021 | – | – | – | – | -3740.0% |
| 2020 | – | – | – | – | -66.67% |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology